National Diabetes Audit
National Diabetes Audit
The National Diabetes Audit (NDA) is the one of the largest annual clinical audits in the world, integrating data from both primary and secondary care sources, making it the most comprehensive audit of its kind.
To find out more about the NDA Programme check out this short presentation.
2015 - 2016 Audit Collection National Participation Results
The National Diabetes Audit 2015-16 closed in August 2016. The audit team would like to thank everyone who participated or supported participation in the audit and because of all the hard work participation in the audit has increased; 82.4 per cent of general practices in England and Wales participated in the 2015-2016 National Diabetes Audit. Results for Care Processes and Treatment Targets will be published early in 2017. The participation report can be downloaded here.
We have also developed a new interactive dashboard which can be viewed here. You can select your CCG or LHB to display participation rates for the past 3 years and view participation for other areas
The next collection
You can register your contact details with the NDA team ahead of the next collection of the audit. We will keep you up to date with the latest information about the audit and how to participate. Please include the following in your email:- name, email address, practice name, practice code, clinical system.
New Reporting Format
Report 1: Care Processes and Treatment Targets for 2013-14 and 2014-15 was published on 28 January 2016. This year we published the main report as a PowerPoint presentation to help CCGs and diabetes leads disseminate the findings locally. We also published GP practice and specialist unit reports for the first time. The report can be found here http://www.digital.nhs.uk/pubs/ndauditcorerep1415.
The audit plans to report the results for 2015-16 Care Processes and Treatment Targets early in 2017 using the same format.
Lessons Learned from 2013-14 and 2014-15
Following the drop in GP practice participation for 2013-14 and 2014-15 the National Diabetes Team have been busy gathering feedback from Clinical Commissioning Groups (CCGs), Strategic Clinical Networks (SCNs) and GP practices to find out what the barriers were to participation, and what helped enable practices to participate in the audit. We have produced two reports, the main report details the full findings and recommendations, and a summary report that contains the key information. These can be found under Guidance for CCGs and Clinical Networks on the right hand side of this page
What does it measure?
The National Diabetes Audit is a major national clinical audit, which measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards, in England and Wales. The NDA collects and analyses data for use by a range of stakeholders to drive changes and improvements in the quality of services and health outcomes for people with diabetes.
The National Diabetes Audit (NDA) answers four key questions based on the diabetes National Service Framework (NSF):
- Is everyone with diabetes diagnosed and recorded on a practice diabetes register?
- What percentage of people registered with diabetes received the nine NICE key processes of diabetes care?
- What percentage of people registered with diabetes achieved NICE defined treatment targets for glucose control, blood pressure and blood cholesterol?
- For people with registered diabetes what are the rates of acute and long term complications (disease outcomes)?
Aims and Objectives
The NDA aims to improve the quality of patient care by enabling NHS organisations to:
- compare their outcomes of care with similar NHS organisations
- identify and share best practice
- identify gaps or shortfalls in commissioning services
- assess local practice against NSF for diabetes and NICE guidelines and drive service improvement
- provide a more comprehensive picture of diabetes care and outcomes in England and Wales
Through participation in the audit, local services are able to benchmark their performance and identify where they are performing well, and improve the quality of treatment and care they provide. On a national level, wide participation in the audit also provides an overview of the quality of care being provided in England and Wales.
Who manages the audit?
The National Diabetes Audit (NDA) is commissioned by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit Programme (NCA) and delivered by the Health and Social Care Information Centre in partnership with Diabetes UK and the National Cardiovascular Intelligence Network (part of Public Health England). The NDA receives expert input from clinicians and people with diabetes across England and Wales
Analysing your data
A series of reports are available in the catalogue that will provide you with information on:
- Audit participation in primary and secondary care
Data tables with information:
- care processes (percentage recorded)
- HbA1c results
- patient age distribution
- average age and BMI
- diabetes type distribution
- ketoacidosis episodes
Further in-depth analysis at a national and local level on:
- registration and prevalence
- care processes
- treatment targets
Data Access Requests
If you require access to the NDA dataset please contact the diabetes team to discuss your needs. Following initial discussions we will then advise you how to apply for the data.
Use of Audit Tools and Documentation Outside of the Clinical Audit
You hereby agree that in downloading or using the documents or tools on this web page for any use outside of the project for which it was developed, you are entering into a royalty free, non-exclusive, licence agreement with the Healthcare Quality Improvement Partnership under the following Terms and Conditions:
All information, software, products and related graphics contained in the audit tool or data collection form are provided for non commercial purposes "as is" without warranty, including but not limited to the implied warranties of satisfactory quality, fitness for a particular purpose, title and non-infringement of third party intellectual property rights. In no event shall HQIP be liable for any direct, indirect, incidental, special or consequential damages for loss of profits, revenue, data or use incurred by you or any third party, whether in action in contract, tort, or otherwise, arising from your access to, or use of, the audit tool or form. HQIP make no representations about the suitability, reliability, or timeliness, and accuracy of the information, software, products and related graphics contained in the audit tool or forms. HQIP reserves the right to make improvements, changes or updates to forms or tools at any time without notice.
Guidance for patients
Access the audit reports
Guidance for GP Practices
- NDA GP Letter [143kb]
- Further Information for GPs [25kb]
- Poster for Practices [161kb]
- Fair Processing [2Mb]
- 10 reasons why GP practices should participate in the NDA [181kb]
- Primary Care Extraction Specification v11.1 [633kb]
- Read Codes for Dissent and Structured Education v1.0 [279kb]
- MIQUEST queries information
Guidance for Specialist Services
- How to register or check an Open Exeter account v1.0 (PDF) [371kb]
- Open Exeter Registration_Trust Form (PDF) [58kb]
- Secondary Care Specification 2015-2016 [188kb]
- Poster for Clinics [160kb]
- 10 reasons why your clinic should participate in the NDA [182kb]
Guidance for CCGs and Clinical Networks
- Lessons Learned from 2013-2015 and Plans for Improvement in England [678kb]
- Summary of lessons learned from 2013-2015 [889kb]
- Maximising participation in the NDA - CCG guidance [289kb]
- Healthcare Quality Improvement Partnership (HQIP) (external)
- Diabetes UK (external)
- Association of British Clinical Diabetologists (ABCD) (external)
- Royal College of Paediatrics and Child Health (through the National Diabetes Paediatric Audit (external)
- National Diabetes Information Service (external)